
Snoval Pharmaceuticals Pvt Ltd
Pharmaceutical company specializing in manufacturing, importing, exporting, and distributing medicines, chemicals, and cosmetics.
Pharmaceutical company specializing in manufacturing, importing, exporting, and distributing medicines, chemicals, and cosmetics.
Snoval Pharmaceuticals Pvt Ltd (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 1983 and has a history of 42 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹18.75 Cr.
Pallavi Lakdawala, Kirtikumar Lakdawala, Rakesh Lakdawala, and One other member serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
-
U24239MH1983PTC029344
029344
Private Limited Indian Non-Government Company
18 Feb 1983
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pallavi Lakdawala ![]() | Director | 01-Jan-1999 | Current |
Kirtikumar Lakdawala ![]() | Director | 18-Jul-1995 | Current |
Rakesh Lakdawala ![]() | Director | 01-Jan-1999 | Current |
Jignesh Lakdawala ![]() | Director | 01-Jan-1999 | Current |
Snoval Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.98% decrease in profit. The company's net worth moved up by a moderate rise of 6.1%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Snoval Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Pallavi Lakdawala and Kirtikumar Lakdawala are mutual person
Pallavi Lakdawala, Kirtikumar Lakdawala and 2 more are mutual person
Pallavi Lakdawala and Kirtikumar Lakdawala are mutual person
₹187.50 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
19 Jan 2022 | Hdfc Bank Limited | ₹6.00 Cr | Open |
28 Jul 2004 | Union Bank Of India | ₹12.75 Cr | Open |
Unlock and access historical data on people associated with Snoval Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Snoval Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snoval Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Snoval Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
30 Sep 2024
Snoval Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
31 Mar 2024
A charge with Hdfc Bank Limited amounted to Rs. 60.00 M with Charge ID 100529787 was registered on 19 Jan 2022.
19 Jan 2022
A charge with Union Bank Of India of Rs. 127.50 M registered on 28 Jul 2004 with Charge ID 90165555 was modified on 02 Aug 2013.
02 Aug 2013
A charge with Union Bank Of India amounted to Rs. 127.50 M with Charge ID 90165555 was registered on 28 Jul 2004.
28 Jul 2004
Pallavi Kirtikumar Lakdawala was appointed as a Director was appointed as a Director on 01 Jan 1999 & has been associated with this company since 26 years 2 months .
01 Jan 1999
Snoval Pharmaceuticals Pvt Ltd was incorporated on 18 Feb 1983.
The authorized share capital of Snoval Pharmaceuticals Pvt Ltd is ₹ 0.50 M and paid-up capital is ₹ 0.40 M.
Currently 4 directors are associated with Snoval Pharmaceuticals Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Snoval Pharmaceuticals Pvt Ltd is Plot No 77/4Lakdi Bunder Darukhana India, Mumbai, Maharashtra, 400010.
The corporate identification number (CIN) of Snoval Pharmaceuticals Pvt Ltd is U24239MH1983PTC029344 and the company number is 029344 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2022 indicates that The net worth of Snoval Pharmaceuticals Pvt Ltd has experienced an upsurge of 6.10%.
As per the financial statements for fiscal Year 2022, The total open charges for Snoval Pharmaceuticals Pvt Ltd amount to ₹ 18.75 Cr.
The most recent Balance Sheet for Snoval Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.